aSCore: LONG-TERM EXPERIENCE WITH ABATACEPT SC IN ROUTINE CLINICAL

Projekt

aSCore: LONG-TERM EXPERIENCE WITH ABATACEPT SC IN ROUTINE CLINICAL

Abgeschlossen · 2015 bis 2017

Forrer Silvia, Schmidig Kathrin, Müller Rüdiger, Bartz-Batliner Mira, Hutz Carina Liane

Art

Klinische Forschung

Reichweite

Multizentrisch, KSSG als teilnehmendes Zentrum

Bereiche

Rheumatologie

Status

Abgeschlossen

Start

2015

Ende

2017

Finanzierungsart

Industrie

Studiendesign

Study Design: This is a non-interventional, multicenter, study onsisting of 2 prospective cohorts of patients diagnosed with moderate to severe active RA and initiated/treated with abatacept SC.

Schlagwörter (Tags)

abatacept, Rheumatoid arthritis

Kurzbeschreibung/Zielsetzung

STUDY DESIGN
Overview of Study Design
This is a non-interventional, multicenter, study consisting of 2 prospective cohorts of patients diagnosed with moderate to severe active RA and initiated/treated with abatacept SC. In some countries, patients can only be included in an observational study if already under treatment, so that inclusion in the study is clearly distinguished from therapeutic decision.
The 2 cohorts will be defined as follows:
 Cohort 1 will focus on patients naïve of abatacept and any other biologics agents and
 Cohort 2 will focus on patients naïve of abatacept and who previously failed one or more
biologic treatment.